{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:24Z","timestamp":1791925704664,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00280-020-04125-w","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T21:09:25Z","timestamp":1598044165000},"page":"419-426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Aloin alleviates doxorubicin-induced cardiotoxicity in rats by abrogating oxidative stress and pro-inflammatory cytokines"],"prefix":"10.1007","volume":"86","author":[{"given":"Lalit","family":"Birari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Wagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpesh R.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh B.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banappa","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sateesh","family":"Belemkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer N.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreesh","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2336-6764","authenticated-orcid":false,"given":"Chandragouda R.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"issue":"04","key":"4125_CR1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-2006-962735","volume":"53","author":"Q Groom","year":"1987","unstructured":"Groom Q, Reynolds T (1987) Barbaloin in aloe species. Planta Med 53(04):345\u2013348","journal-title":"Planta Med"},{"issue":"1","key":"4125_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jtcme.2014.10.006","volume":"5","author":"MH Radha","year":"2015","unstructured":"Radha MH, Laxmipriya NP (2015) Evaluation of biological properties and clinical effectiveness of Aloe vera: a systematic review. J Tradit Complement Med 5(1):21\u201326","journal-title":"J Tradit Complement Med"},{"issue":"1","key":"4125_CR3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00726-011-1166-x","volume":"44","author":"C Tabolacci","year":"2013","unstructured":"Tabolacci C, Rossi S, Lentini A, Provenzano B, Turcano L, Facchiano F, Beninati S (2013) Aloin enhances cisplatin antineoplastic activity in B16\u2013F10 melanoma cells by transglutaminase-induced differentiation. Amino Acids 44(1):293\u2013300","journal-title":"Amino Acids"},{"issue":"4","key":"4125_CR4","first-page":"71","volume":"4","author":"J Na","year":"2014","unstructured":"Na J, Sirdaartaa J, Cocka I (2014) The anti-proliferative properties of Australian plants with high antioxidant capacities against cancer cell lines. Pharmacogn Commun 4(4):71\u201382","journal-title":"Pharmacogn Commun"},{"issue":"2","key":"4125_CR5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0891-5849(02)01242-X","volume":"34","author":"WG Wamer","year":"2003","unstructured":"Wamer WG, Vath P, Falvey DE (2003) In vitro studies on the photobiological properties of aloe emodin and aloin A. Free Radic Biol Med 34(2):233\u2013242","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"4125_CR6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.foodchem.2004.06.018","volume":"91","author":"B Tian","year":"2005","unstructured":"Tian B, Hua Y (2005) Concentration-dependence of prooxidant and antioxidant effects of aloin and aloe-emodin on DNA. Food Chem 91(3):413\u2013418","journal-title":"Food Chem"},{"key":"4125_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-020-01833-1","volume":"393","author":"LA Birari","year":"2020","unstructured":"Birari LA, Mahajan UB, Patil KR, Patil DD, Bagul NA, Belemkar S, Goyal SN, Ojha S, Patil CR (2020) Aloin protects against arsenic trioxide\u2013induced myocardial membrane damage and release of inflammatory cytokines. Naunyn-Schmiedeberg's Archives Pharmacol 393:1\u20138","journal-title":"Naunyn-Schmiedeberg's Archives Pharmacol"},{"issue":"10","key":"4125_CR8","first-page":"4105","volume":"5","author":"A Kumar","year":"2014","unstructured":"Kumar A, Gautam B, Dubey C, Tripathi PK (2014) A review: role of doxorubicin in treatment of cancer. Int J Pharm Sci Res 5(10):4105","journal-title":"Int J Pharm Sci Res"},{"key":"4125_CR9","first-page":"340","volume-title":"Methods in enzymology","author":"G Minotti","year":"2004","unstructured":"Minotti G, Recalcati S, Menna P, Salvatorelli E, Corna G, Cairo G (2004) Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms. Methods in enzymology. Elsevier, Amsterdam, pp 340\u2013361"},{"key":"4125_CR10","first-page":"670","volume":"6","author":"RB Weiss","year":"1992","unstructured":"Weiss RB (1992) The anthracyclines: will we ever find a better doxorubicin? Semin oncol 6:670\u2013686","journal-title":"Semin oncol"},{"issue":"2","key":"4125_CR11","first-page":"61","volume":"8","author":"S Shah","year":"2009","unstructured":"Shah S, Mohan M, Kasture S, Sanna C, Maxia A (2009) Protective effect of Ephedra nebrodensis on doxorubicin-induced cardiotoxicity in rats. Iran J Pharmacol Ther 8(2):61\u201360","journal-title":"Iran J Pharmacol Ther"},{"issue":"3","key":"4125_CR12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ddr.21006","volume":"73","author":"AY Esmat","year":"2012","unstructured":"Esmat AY, Said MM, Hamdy GM, Soliman AA, Khalil SA (2012) In vivo and in vitro studies on the antioxidant activity of aloin compared to doxorubicin in rats. Drug Dev Res 73(3):154\u2013165","journal-title":"Drug Dev Res"},{"key":"4125_CR13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fphar.2020.00815","volume":"11","author":"L Li","year":"2020","unstructured":"Li L, Li J, Wang Q, Zhao X, Yang D, Niu L, Yang Y, Zheng X, Hu L, Li Y (2020) Shenmai injection protects against doxorubicin-induced cardiotoxicity via maintaining mitochondrial homeostasis. Front Pharmacol 11:815","journal-title":"Front Pharmacol"},{"issue":"6","key":"4125_CR14","first-page":"966","volume":"58","author":"P Potemski","year":"2006","unstructured":"Potemski P, Polakowski P, Wiktorowska-Owczarek AK, Owczarek J, Pluzanska A, Orszulak-Michalak D (2006) Amifostine improves hemodynamic parameters in doxorubicin-pretreated rabbits. Pharmacol Rep 58(6):966","journal-title":"Pharmacol Rep"},{"issue":"1","key":"4125_CR15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2298\/VSP110905041D","volume":"70","author":"V Dragojevi\u0107-Simi\u0107","year":"2013","unstructured":"Dragojevi\u0107-Simi\u0107 V, Dobri\u0107 S, Ja\u0107evi\u0107 V, Bokonji\u0107 D, Milosavljevi\u0107 I, Kova\u010devi\u0107 A, Miki\u0107 D (2013) Efficacy of amifostine in protection against doxorubicin-induced acute cardiotoxic effects in rats. Vojnosanit Pregl 70(1):38\u201345","journal-title":"Vojnosanit Pregl"},{"issue":"17","key":"4125_CR16","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0024-3205(98)00419-6","volume":"63","author":"G Falcone","year":"1998","unstructured":"Falcone G, Filippelli W, Mazzarella B, Tufano R, Mastronardi P, Filippelli A, Berrino L, Rossi F (1998) Cardiotoxicity of doxorubicin: effects of 21-aminosteroids. Life Sci 63(17):1525\u20131532","journal-title":"Life Sci"},{"issue":"1","key":"4125_CR17","first-page":"197","volume":"236","author":"RA Jensen","year":"1986","unstructured":"Jensen RA (1986) Doxorubicin cardiotoxicity: contractile changes after long-term treatment in the rat. J Pharmacol Exp Ther 236(1):197\u2013203","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"4125_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tox.2007.09.026","volume":"243","author":"RB Kelishomi","year":"2008","unstructured":"Kelishomi RB, Ejtemaeemehr S, Tavangar SM, Rahimian R, Mobarakeh JI, Dehpour AR (2008) Morphine is protective against doxorubicin-induced cardiotoxicity in rat. Toxicology 243(1\u20132):96\u2013104","journal-title":"Toxicology"},{"issue":"2","key":"4125_CR19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00001813-200402000-00011","volume":"15","author":"VM Dragojevic-Simic","year":"2004","unstructured":"Dragojevic-Simic VM, Dobric SL, Bokonjic DR, Vucinic ZM, Sinovec SM, Jacevic VM, Dogovic NP (2004) Amifostine protection against doxorubicin cardiotoxicity in rats. Anticancer Drugs 15(2):169\u2013178","journal-title":"Anticancer Drugs"},{"issue":"12","key":"4125_CR20","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s12272-014-0370-0","volume":"37","author":"Y Cui","year":"2014","unstructured":"Cui Y, Ye Q, Wang H, Li Y, Xia X, Yao W, Qian H (2014) Aloin protects against chronic alcoholic liver injury via attenuating lipid accumulation, oxidative stress and inflammation in mice. Arch Pharmacal Res 37(12):1624\u20131633","journal-title":"Arch Pharmacal Res"},{"issue":"2","key":"4125_CR21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0960327113493307","volume":"33","author":"O Hamiza","year":"2014","unstructured":"Hamiza O, Rehman M, Khan R, Tahir M, Khan A, Lateef A, Sultana S (2014) Chemopreventive effects of aloin against 1, 2-dimethylhydrazine-induced preneoplastic lesions in the colon of Wistar rats. Hum Exp Toxicol 33(2):148\u2013163","journal-title":"Hum Exp Toxicol"},{"issue":"6","key":"4125_CR22","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Y Octavia","year":"2012","unstructured":"Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL (2012) Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52(6):1213\u20131225","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"4125_CR23","first-page":"69","volume":"6","author":"N Maghamiour","year":"2014","unstructured":"Maghamiour N, Safaie N (2014) High creatine kinase (CK)-MB and lactate dehydrogenase in the absence of myocardial injury or infarction: a case report. J Cardiovasc Thorac Res 6(1):69","journal-title":"J Cardiovasc Thorac Res"},{"issue":"3","key":"4125_CR24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.tice.2017.03.007","volume":"49","author":"HN Mustafa","year":"2017","unstructured":"Mustafa HN, Hegazy GA, El Awdan SA, AbdelBaset M (2017) Protective role of CoQ10 or L-carnitine on the integrity of the myocardium in doxorubicin induced toxicity. Tissue Cell 49(3):410\u2013426","journal-title":"Tissue Cell"},{"issue":"2","key":"4125_CR25","first-page":"125","volume":"23","author":"Y-N Yang","year":"2007","unstructured":"Yang Y-N, Chuang Y-C, Yin W-H, Young MS (2007) Catecholamine-induced cardiomyopathy secondary to pheochromocytoma mimicking fulminant acute myocarditis. Acta Cardiologica Sinica 23(2):125\u2013130","journal-title":"Acta Cardiologica Sinica"},{"key":"4125_CR26","first-page":"1","volume":"2016","author":"P Xia","year":"2016","unstructured":"Xia P, Liu Y, Cheng Z (2016) Signaling pathways in cardiac myocyte apoptosis. BioMed Res Int 2016:1\u201322","journal-title":"BioMed Res Int"},{"issue":"2","key":"4125_CR27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1034\/j.1600-0773.2001.088002106.x","volume":"88","author":"PN Karamanakos","year":"2001","unstructured":"Karamanakos PN, Pappas P, Stephanou P, Marselos M (2001) Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism. Pharmacol Toxicol 88(2):106\u2013110","journal-title":"Pharmacol Toxicol"},{"issue":"4","key":"4125_CR28","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00246-015-1096-6","volume":"36","author":"C Bayram","year":"2015","unstructured":"Bayram C, Cetin I, Tavil B, Yarali N, Ekici F, Is\u0131k P, Tunc B (2015) Evaluation of cardiotoxicity by tissue Doppler imaging in childhood leukemia survivors treated with low-dose anthracycline. Pediatr Cardiol 36(4):862\u2013866","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"4125_CR29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/jcms.12345","volume":"54","author":"D Jan\u010di\u0107","year":"2016","unstructured":"Jan\u010di\u0107 D (2016) The role of the European Parliament and the US Congress in shaping transatlantic relations: TTIP, NSA surveillance, and CIA renditions. JCMS J Common Mark Stud 54(4):896\u2013912","journal-title":"JCMS J Common Mark Stud"},{"issue":"4S","key":"4125_CR30","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1143\/JJAP.47.2767","volume":"47","author":"Y Niki","year":"2008","unstructured":"Niki Y, Manzawa Y, Kametani S, Shibata T (2008) Moving-object-localization hardware algorithm employing OR-amplification of pixel activities. Jpn J Appl Phys 47(4S):2767","journal-title":"Jpn J Appl Phys"},{"issue":"6","key":"4125_CR31","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3892\/ol.2012.931","volume":"4","author":"O Zitka","year":"2012","unstructured":"Zitka O, Skalickova S, Gumulec J, Masarik M, Adam V, Hubalek J, Trnkova L, Kruseova J, Eckschlager T, Kizek R (2012) Redox status expressed as GSH: GSSG ratio as a marker for oxidative stress in paediatric tumour patients. Oncol Lett 4(6):1247\u20131253","journal-title":"Oncol Lett"},{"key":"4125_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/1521020","volume":"2017","author":"D Cappetta","year":"2017","unstructured":"Cappetta D, De Angelis A, Sapio L, Prezioso L, Illiano M, Quaini F, Rossi F, Berrino L, Naviglio S, Urbanek K (2017) Oxidative stress and cellular response to doxorubicin: a common factor in the complex milieu of anthracycline cardiotoxicity. Oxid Med Cell Longev 2017:1\u201313","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"4125_CR33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nprot.2009.197","volume":"5","author":"CJ Weydert","year":"2010","unstructured":"Weydert CJ, Cullen JJ (2010) Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc 5(1):51","journal-title":"Nat Protoc"},{"key":"4125_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/450390","volume":"2014","author":"F Capone","year":"2014","unstructured":"Capone F, Guerriero E, Sorice A, Colonna G, Storti G, Pagliuca J, Castello G, Costantini S (2014) Synergistic antitumor effect of Doxorubicin and tacrolimus (FK506) on hepatocellular carcinoma cell lines. Sci World J 2014:1\u20139","journal-title":"Sci World J"},{"issue":"1","key":"4125_CR35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/0253-7613.91871","volume":"44","author":"AV Swamy","year":"2012","unstructured":"Swamy AV, Gulliaya S, Thippeswamy A, Koti BC, Manjula DV (2012) Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian J Pharmacol 44(1):73","journal-title":"Indian J Pharmacol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-020-04125-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-020-04125-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-020-04125-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T23:38:31Z","timestamp":1629243511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-020-04125-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["4125"],"URL":"https:\/\/doi.org\/10.1007\/s00280-020-04125-w","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]},"assertion":[{"value":"10 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was examined and approved by the Institutional Animal Ethics Committee (Reg. No. 651\/PO\/ReBi\/S\/02\/CPCSEA) established under the guidelines of Committee for the Purpose of Control and Supervision of Experiments of Animals (CPCSEA), Government of India.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}